Details of Protein
General Information of Protein (ID: PRT00697) | |||||
---|---|---|---|---|---|
Name | Proton myo-inositol cotransporter (SLC2A13) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
H(+)-myo-inositol cotransporter; Hmit; H(+)-myo-inositol symporter; Solute carrier family 2 member 13; Slc2a13
|
||||
Gene Name | Slc2a13 | Gene ID | |||
UniProt ID | |||||
Family | Sugar transporter (ST) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MSRKASEDVEYTLRSLSSLMGERRRRQPEPGAPGGERSLLAAESAASLQGAELERAARRQ
FQRDETPAFVYAAAAFSALGGFLFGYDTGVVSGAMLLLRRQMRLGAMWQELLVSGAVGAA AVAALAGGALNGALGRRSAILLASALCTVGSAVLAAAANKETLLAGRLVVGLGIGIASMT VPVYIAEVSPPNLRGRLVTINTLFITGGQFFASVVDGAFSYLQKDGWRYMLGLAAIPAVI QFLGFLFLPESPRWLIQKGQTQKARRILSQMRGNQTIDEEYDSIRNSIEEEEKEASAAGP IICRMLSYPPTRRALAVGCGLQMFQQLSGINTIMYYSATILQMSGVEDDRLAIWLASITA FTNFIFTLVGVWLVEKVGRRKLTFGSLAGTTVALTILALGFLLSAQVSPRVTFRPTAPSG QNATCTEYSYCNECMLDPDCGFCYKINSSAVIDSSCVPVNKASTNEAAWGRCENETKFKA EDVHWAYSFCPTPYSWTALVGLVLYLVFFAPGMGPMPWTVNSEIYPLWARSTGNACSAGI NWIFNVLVSLTFLHTAEYLTYYGAFFLYAGFAAVGLLFVYGCLPETKGKKLEEIESLFDH RLCTCGTADSDEGRYIEYIRVKGSNYHLSDNDASDVE |
||||
Function | H(+)-myo-inositol cotransporter. Can also transport related stereoisomers. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Organic oxygen compounds | ||||||
myo-Inositol | Click to Show/Hide the Full List of Regulating Pair(s): 6 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (LL22/23AA+YIRV599/602AIRA) of Slc2a13 | |||||
Induced Change | myo-Inositol concentration: increase (FC = 6) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (LL22/23AA+YIRV599/602AIRA) of Slc2a13 leads to the increase of myo-inositol levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (RRR4/6AAA +LL22/23AA) of Slc2a13 | |||||
Induced Change | myo-Inositol concentration: increase (FC = 6) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (RRR4/6AAA +LL22/23AA) of Slc2a13 leads to the increase of myo-inositol levels compared with control group. | |||||
Regulating Pair (3) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (RRR4/6AAA +LL22/23AA+YIRV599/602AIRA) of Slc2a13 | |||||
Induced Change | myo-Inositol concentration: increase (FC = 120) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (RRR4/6AAA +LL22/23AA+YIRV599/602AIRA) of Slc2a13 leads to the increase of myo-inositol levels compared with control group. | |||||
Regulating Pair (4) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (RRR4/6AAA+YIRV599/602AIRA) of Slc2a13 | |||||
Induced Change | myo-Inositol concentration: increase (FC = 6) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (RRR4/6AAA+YIRV599/602AIRA) of Slc2a13 leads to the increase of myo-inositol levels compared with control group. | |||||
Regulating Pair (5) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (YIRV599/602AIRA) of Slc2a13 | |||||
Induced Change | myo-Inositol concentration: increase (FC = 6) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (YIRV599/602AIRA) of Slc2a13 leads to the increase of myo-inositol levels compared with control group. | |||||
Regulating Pair (6) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Mutation (LL22/23AA) of Slc2a13 | |||||
Induced Change | myo-Inositol concentration: increase (FC = 6) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that mutation (LL22/23AA) of Slc2a13 leads to the increase of myo-inositol levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain. EMBO J. 2001 Aug 15;20(16):4467-77. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.